Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Equine Healthcare Products Market $22.6 Billion by 2027

The global market for equine healthcare consisting of diagnostic, therapeutic and supplemental products estimated to reach $22.6 billion by 2027, declining at a CAGR of 1% over the forecast period.

  • Although, equine diagnostic and therapeutic products market growth is driven by increasing aging population and related disorders, factors such as globally declining equine population, industry fragmentation, high cost of healthcare, feed, and supplements are restraining it.
    • However, according to AHP equine industry survey, the equine industry has found stability and shows positive signs of growth over the forecast period.
Global Equine Healthcare Products Market

The global market for equine diagnostic, therapeutic and supplemental products report estimates the market size ($million 2017 to 2027) and forecast (CAGR% 2021 to 2027).

The global equine healthcare market is segmented by diagnostic products [genotyping analysis (quality analyzers/genotype analyzer kits, genetic disease identification products), pregnancy and gestation products (ultraSound devices, urine test kits); by therapeutic products (antibacterials, anti-inflammatory drugs, antiprotozoals, antivirals, dopamine agonists, laxatives, vaccines); and by supplement products [performance supplements (electrolyte supplements, proteins and amino acids supplements, vitamin supplements), and protection products such as prosthetic products.

  • Based on overall product segments, supplement products segment accounted for the largest share of the total equine healthcare market, followed by therapeutic products and diagnostic products segments, respectively.
    • The equine diagnostic products segment anticipated to grow at the fastest rate throughout the forecast period, followed by therapeutic products segment, respectively.

The global market for equine healthcare products research report is divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA) and Rest of the World.

  • By geography, North America accounted for the highest share of the global equine healthcare market followed by rest of the world and Asia Pacific region, and similar market trends are expected over the forecast period.
    • In developed and developing countries, there has been increasing number of equine practices and referral hospitals that provide high levels of specialization.
  • In emerging markets, equine medicines may be completely locally unavailable; those that are available may be beyond the resources of local producers or may only be available in small pack sizes.
    • The lack of infrastructure may also make it difficult to transport medicines and vaccines to where they are needed because of poor transport links or lack of refrigeration, and networks of laboratories for conducting health tests often do not exist.
      • Some countries, e.g., India, have made rapid progress in recent years in increasing refrigeration capacity. However, most emerging markets are further behind in adding additional capacity.

The global market for equine healthcare products (diagnostic, therapeutic and supplemental) market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global equine products market and included in this report are Affymetrix, Inc., Bayer AG, Boerhringer Ingelheim Vetmedica, Inc. (BIVI), Elanco Animal Health, Equine Diagnostics, Equine Orthotics and Prosthetics, Equine Products (UK) Ltd., Merck Animal Health, Purina Mills, LLC, Signostics Limited, and Zoetis, Inc.

  • Diagnostic Products
    • Genotyping Analysis
      • Quality Analyzers/Genotype Analyzers Kits
      • Genetic Disease Identification Products (Semen Quality Analyzers)
    • Pregnancy and Gestation
      • Ultrasound Devices
      • Urine Test Kits
  • Therapeutic Products
    • Antibacterials
    • Anti-inflammatory Drugs
    • Antiprotozoals
    • Antivirals
    • Dopamine Agonists
    • Laxatives
    • Vaccines
  • Supplement Products
    • Performance Supplements
      • Electrolyte Supplements
      • Proteins and Amino Acids Supplements
      • Vitamin Supplements
      • Others
    • Protection Products
      • Prosthetic products
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Affymetrix, Inc.
    • Bayer AG
    • Boerhringer Ingelheim Vetmedica, Inc. (BIVI)
    • Elanco Animal Health
    • Equine Diagnostics
    • Equine Orthotics and Prosthetics
    • Equine Products (UK) Ltd.
    • Merck Animal Health
    • Purina Mills, LLC
    • Signostics Limited
    • Zoetis, Inc.

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 463-5840
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]